No. |
GO terms |
Targets |
# of targets |
p-value (EPT)↑ |
p-value (EPD) |
1 |
ligand-dependent nuclear receptor transcription coactivator activity |
NCOA2;PPARG |
2 |
0.0007 |
0.048 |
2 |
RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding |
PPARG;RXRA |
2 |
0.0038 |
0.091 |
3 |
transcription coactivator activity |
NCOA2;RXRA |
2 |
0.0042 |
0.068 |
4 |
steroid hormone receptor activity |
PPARG;RXRA |
2 |
0.0042 |
0.1 |
5 |
chromatin binding |
NCOA2;PPARG |
2 |
0.0059 |
0.1 |
6 |
transcription factor activity, sequence-specific DNA binding |
PPARG;RXRA |
2 |
0.0059 |
0.11 |
7 |
prostaglandin receptor activity |
PPARG |
1 |
0.0064 |
0.04 |
8 |
retinoic acid-responsive element binding |
RXRA |
1 |
0.007 |
0.058 |
9 |
9-cis retinoic acid receptor activity |
RXRA |
1 |
0.007 |
0.047 |
10 |
RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding |
NCOA2 |
1 |
0.0071 |
0.037 |
11 |
thyroid hormone receptor coactivator activity |
NCOA2 |
1 |
0.0071 |
0.037 |
12 |
retinoid X receptor binding |
PPARG |
1 |
0.0076 |
0.044 |
13 |
vitamin D receptor binding |
RXRA |
1 |
0.0078 |
0.087 |
14 |
RNA polymerase II regulatory region DNA binding |
PPARG |
1 |
0.0081 |
0.04 |
15 |
DNA binding |
PPARG;RXRA |
2 |
0.0082 |
0.12 |
16 |
arachidonic acid binding |
PPARG |
1 |
0.0085 |
0.04 |
17 |
enzyme binding |
PPARG;RXRA |
2 |
0.0085 |
0.19 |
18 |
ligand-dependent nuclear receptor binding |
NCOA2 |
1 |
0.0093 |
0.038 |
19 |
retinoic acid receptor activity |
RXRA |
1 |
0.0093 |
0.044 |
20 |
activating transcription factor binding |
PPARG |
1 |
0.01 |
0.04 |
21 |
alpha-actinin binding |
PPARG |
1 |
0.01 |
0.05 |
22 |
nuclear hormone receptor binding |
NCOA2 |
1 |
0.011 |
0.04 |
23 |
histone acetyltransferase activity |
NCOA2 |
1 |
0.012 |
0.048 |
24 |
transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
PPARG |
1 |
0.014 |
0.053 |
25 |
chromatin DNA binding |
RXRA |
1 |
0.014 |
0.038 |
26 |
core promoter sequence-specific DNA binding |
PPARG |
1 |
0.016 |
0.067 |
27 |
zinc ion binding |
PPARG;RXRA |
2 |
0.017 |
0.21 |
28 |
RNA polymerase II regulatory region sequence-specific DNA binding |
RXRA |
1 |
0.029 |
0.048 |
29 |
RNA polymerase II core promoter proximal region sequence-specific DNA binding |
NCOA2 |
1 |
0.031 |
0.085 |
30 |
transcription regulatory region DNA binding |
PPARG |
1 |
0.031 |
0.067 |
31 |
sequence-specific DNA binding |
RXRA |
1 |
0.032 |
0.066 |
32 |
drug binding |
PPARG |
1 |
0.07 |
0.19 |
33 |
protein heterodimerization activity |
RXRA |
1 |
0.078 |
0.1 |